Brandywine Oak Private Wealth LLC Reduces Position in The Chemours Company (NYSE:CC)

Brandywine Oak Private Wealth LLC cut its stake in shares of The Chemours Company (NYSE:CC) by 6.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 25,051 shares of the specialty chemicals company’s stock after selling 1,605 shares during the quarter. Brandywine Oak Private Wealth LLC’s holdings in Chemours were worth $790,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of the stock. Hexagon Capital Partners LLC purchased a new position in shares of Chemours during the 4th quarter valued at $25,000. Bryn Mawr Capital Management LLC raised its stake in Chemours by 135.7% during the 4th quarter. Bryn Mawr Capital Management LLC now owns 27,205 shares of the specialty chemicals company’s stock valued at $858,000 after purchasing an additional 15,662 shares during the period. State of New Jersey Common Pension Fund D lifted its holdings in Chemours by 7.0% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 95,771 shares of the specialty chemicals company’s stock worth $3,021,000 after purchasing an additional 6,268 shares in the last quarter. Bfsg LLC bought a new position in Chemours in the 4th quarter worth approximately $62,000. Finally, Alaska Permanent Fund Corp raised its position in shares of Chemours by 2.5% during the fourth quarter. Alaska Permanent Fund Corp now owns 74,498 shares of the specialty chemicals company’s stock valued at $2,350,000 after buying an additional 1,798 shares during the last quarter. Institutional investors own 76.26% of the company’s stock.

Chemours Trading Down 1.5 %

Shares of NYSE:CC traded down $0.41 during trading on Wednesday, hitting $26.34. The company had a trading volume of 538,255 shares, compared to its average volume of 1,808,001. The stock has a market cap of $3.92 billion, a price-to-earnings ratio of -16.89 and a beta of 2.00. The company has a debt-to-equity ratio of 5.40, a current ratio of 1.54 and a quick ratio of 1.00. The company has a fifty day simple moving average of $26.66 and a two-hundred day simple moving average of $27.85. The Chemours Company has a one year low of $15.10 and a one year high of $39.05.

Chemours (NYSE:CC) last issued its quarterly earnings results on Tuesday, April 30th. The specialty chemicals company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.25 by $0.07. Chemours had a positive return on equity of 51.73% and a negative net margin of 3.80%. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.35 billion. During the same period last year, the company earned $0.98 earnings per share. Chemours’s revenue was down 12.1% on a year-over-year basis. As a group, equities analysts forecast that The Chemours Company will post 2.23 earnings per share for the current year.

Chemours Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Wednesday, May 15th will be given a dividend of $0.25 per share. The ex-dividend date is Tuesday, May 14th. This represents a $1.00 annualized dividend and a dividend yield of 3.80%. Chemours’s dividend payout ratio (DPR) is presently -64.52%.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on CC shares. BMO Capital Markets raised shares of Chemours from an “underperform” rating to an “outperform” rating and raised their target price for the company from $19.00 to $34.00 in a research note on Tuesday, April 9th. UBS Group raised their price objective on Chemours from $21.00 to $28.00 and gave the company a “neutral” rating in a research report on Tuesday, April 2nd. Finally, Barclays decreased their target price on Chemours from $32.00 to $30.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 2nd. Seven equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $31.63.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.